RxDoctor Payments DataLook up a doctor →

Jason Ludwig, DO

Family Medicine · Meridian, IDNPI 1144258534

Payments from drug & device makers

$7,479in general payments, 2019–2025

Across 404 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$828
  • AbbVie$491
  • Amgen$482
  • Novo Nordisk$453
  • Pfizer$346
  • Novartis$275
  • plus $4K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca44$828
AbbVie(2 entities)32$491
Amgen(2 entities)25$482
Novo Nordisk27$453
Pfizer22$346
Novartis15$275
Teva Pharmaceuticals USA, Inc.13$253
GSK12$238
Astellas Pharma US Inc10$238
Otsuka America Pharmaceutical, Inc.11$215
Johnson & Johnson13$207
Corium, LLC9$184
Dexcom, Inc.6$172
E.r. Squibb & Sons, L.L.C.9$152
Acadia Pharmaceuticals Inc4$146
Sunovion Pharmaceuticals Inc.10$124
Vanda Pharmaceuticals Inc.6$124
Nestle Healthcare Nutrition Inc.6$121
Bayer5$118
Eisai Inc.7$117
Merck7$116
Boehringer Ingelheim7$114
Sanofi-aventis U.S. LLC6$110
Idorsia Pharmaceuticals US Inc6$105
Lilly USA, LLC5$95
Aimmune Therapeutics, Inc.4$91
Amarin Pharma, Inc.5$89
Mylan Specialty L.p.3$69
Corcept Therapeutics3$68
Medtronic2$67
Boston Scientific2$65
Takeda Pharmaceuticals U.S.A., Inc.5$64
Supernus Pharmaceuticals, Inc.4$61
Arbor Pharmaceuticals, Inc.4$59
Philips North America LLC2$57
Abbott3$57
Exact Sciences2$56
Biogen3$54
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$51
Esperion Therapeutics, Inc.3$45
Sumitomo Pharma America, Inc.2$40
Regeneron Healthcare Solutions, Inc.2$39
Antares Pharma, Inc.2$39
Kyowa Kirin, Inc.2$39
Phathom Pharmaceuticals, Inc.2$38
Neurocrine Biosciences, Inc.2$36
Avanir Pharmaceuticals, Inc.2$33
Viatris Specialty LLC2$31
Otsuka Pharmaceutical Development & Commercialization, Inc.2$30
Genentech USA, Inc.2$30
Stryker1$25
Xeris Pharmaceuticals, Inc.1$25
Shield Therapeutics Inc1$25
Acorda Therapeutics, Inc1$23
Alnylam Pharmaceuticals Inc.1$22
Scilex Pharmaceuticals Inc.1$21
Collegium Pharmaceutical, Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$19
Axsome Therapeutics, Inc.1$19
Hologic Sales And Service, LLC1$19

How this compares

$7,479 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho →

Medicare billing

Part B allowed, 2024
$67,771
Medicare patients
328
Services billed
1,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Meridian

See the full list for Idaho →

Where these figures come from

Is this you, or does something look wrong? →